Tag: dosing
AstraZeneca eyes less-frequent Imfinzi dosing with FDA ‘priority’ boost
Merck’s Keytruda recently became the only member of the PD-1/PD-L1 class with an FDA nod for less-frequent dosing—but AstraZeneca doesn’t intend to let it...